HomeCVKD • NASDAQ
add
Cadrenal Therapeutics Inc
Previous close
$0.44
Day range
$0.43 - $0.45
Year range
$0.36 - $3.14
Market cap
6.94M USD
Avg Volume
379.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.76M | -58.20% |
Net income | -1.66M | 67.85% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | -1.76M | 58.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.57M | 63.00% |
Total assets | 7.05M | 57.26% |
Total liabilities | 856.32K | 105.45% |
Total equity | 6.19M | — |
Shares outstanding | 16.01M | — |
Price to book | 1.14 | — |
Return on assets | -56.39% | — |
Return on capital | -63.06% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.66M | 67.85% |
Cash from operations | -1.84M | -29.98% |
Cash from investing | — | — |
Cash from financing | 298.00 | -99.99% |
Net change in cash | -1.84M | -145.95% |
Free cash flow | -1.43M | 51.29% |
About
Founded
2022
Website
Employees
4